PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
29-Jan-2020 Most innovative cancer drugs facing delays in reaching patients The Institute of Cancer Research
29-Jan-2020 New Interactive Good Clinical Practice online learning course now available Jo Burmester
29-Jan-2020 Immutep activities report - late-stage Phase IIb metastatic breast cancer results ETA, TACTI-002 results ETA Immutep Limited
29-Jan-2020 Signant Health Enhances Audit Trail Reporting CapabiliTrialMax® to Improve eCOA Data Integrity Monitoring Signant Health
29-Jan-2020 Nuvisan Pharma Services acquires Inamed GmbH Nuvisan Pharma Services
28-Jan-2020 Registration Opens for SMi’s 20th Annual Pain Therapeutics Conference SMi Group
27-Jan-2020 Hypertrophic Scars Therapeutics Pipeline Analysis, Clinical Trials and Developments Pharma Proff
24-Jan-2020 Dupixent®▼ (dupilumab), accepted for restricted use within NHS Wales for the treatment of moderate to severe atopic dermatitis in adolescents aged 12 years and over1 Sanofi
24-Jan-2020 Dupixent®▼ (dupilumab) available to treat adolescents with moderate to severe atopic dermatitis in Scotland1 Sanofi
24-Jan-2020 Sanofi Completes Acquisition of Synthorx, Inc. Sanofi
24-Jan-2020 Johnson & Johnson Announces $250 Million Commitment to Support Frontline Health Workers, Reaching 100 Million People by 2030 Davos
24-Jan-2020 Momentum of support builds for early lung cancer screening in Scotland Oncimmune
24-Jan-2020 Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen Genmab
24-Jan-2020 Global Contract Research Organisation Expands Services with Oracle Argus Cloud PharSafer
24-Jan-2020 Growing AXON Brighton Team Relocates to Larger New Office AXON
24-Jan-2020 iOnctura raises EUR 15 million in Series A financing to progress its pipeline into clinical development iOnctura
24-Jan-2020 European CNS specialist Neuraxpharm strengthens expansion into Austrian market with acquisition of easypharm Neuraxpharm Group
24-Jan-2020 Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy PTC Therapeutics, Inc
24-Jan-2020 Autolus Announces Proposed Public Offering in the United States Autolus Therapeutics plc
24-Jan-2020 Autolus Announces Pricing of Public Offering Autolus Therapeutics plc